VAC2VAC is a wide ranging collaborative research project funded by IMI2 which aims to develop and validate quality testing approaches for both human and veterinary vaccines using non animal methods.
The initiative that started on 1 March 2016 aims to provide the data to support the ‘Consistency Approach’ for quality control of established vaccines. More information on the project and on the participants can now be found under the following link: www.vac2vac.eu.
European public and private organisations are collaborating in VAC2VAC, a new project funded by the Innovative Medicines Initiative (IMI2) to develop and validate quality testing approaches for both human and veterinary vaccines using non-animal methods.
Three new positions offering exciting challenges to qualified applicants are now available at EVI:
Institut Pasteur currently has a postdoctoral position in malaria vaccine developement. Applications should be made to Prof. Chetan Chitnis chetan [dot] chitnis [at] pasteur [dot] fr by 15 January 2016
EVI extends heartfelt thanks to all our donors, colleagues, collaborators, friends and well wishers, whose presence at this annual event, made it a truly memorable occasion.
EVI wishes you a peaceful, restful Xmas, and we hope to see you at next year's Rendez-Vous.
The full article, entitled "The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine", can be accessed via this link.
- 1 of 11